Can you trust AI for RWE? HealthVerity eXOs validation study says yes
Artificial intelligence is moving quickly into healthcare research, but one question still comes...
The Missing Pieces: How Rare Disease Diagnoses Come Together
Rare diseases may be individually uncommon, but collectively they affect an estimated 30 million people in the United States. Yet for many patients, the path to diagnosis spans years, sometimes decades. Symptoms appear one at a time. Specialists...
The role of real-world data in advancement of Alzheimer’s treatments
One in nine Americans age 65 and older has Alzheimer’s disease (AD), a devastating illness that...
Inside taXonomy, a next-gen closed claims solution for real-world evidence generation
Healthcare claims data are one of the most powerful sources of data in generating real-world...
Rethinking healthcare audience targeting for data-driven precision
Why healthcare marketers need more transparency in audience targeting Healthcare marketers are...
What The Pitt gets right about AI and clinical notes
In Season 2 of The Pitt, Dr. Santos accepts an AI-drafted clinical note and moves on. It’s one of...
Why diagnosis codes alone fall short for long COVID surveillance
When our client, a global pharmaceutical company, set out to better understand long COVID pathways,...
GenAI vs. Agentic AI: The difference for real-world evidence
AI is playing a growing role in real-world evidence, but not all AI serves the same purpose. Two...
Why RWE programs fail under regulatory scrutiny — and what leaders can do about it
FDA has made its expectations for RWE clearer and more structured through recent guidance and...
HPV vaccination trends from 2016 to 2025: Progress and missed opportunities
by: Alexandra Miller, MPH Human papillomavirus (HPV) is one of the most common sexually...
The Missing Pieces: How Rare Disease Diagnoses Come Together
Rare diseases may be individually uncommon, but collectively they affect an estimated 30 million...